Global and Japan Non-Invasive Cancer Diagnostics Market Size, Status and Forecast 2020-2026

Home/Global and Japan Non-Invasive Cancer Diagnostics Market Size, Status and Forecast 2020-2026

Global and Japan Non-Invasive Cancer Diagnostics Market Size, Status and Forecast 2020-2026

Healthcare, Pharma & Healthcare

Publication ID:

QYR11201667

Publication Date:

November 23, 2020

Pages:

Publisher:

QYR

Region:

Global

$3,900.00

Need Custom Market Research Solution?

Want to commission a custom market research to suit your needs? We are here to help. Let us know.

Printer version

Send by email

PDF version

Tabs

Description

Global Non-Invasive Cancer Diagnostics Scope and Market Size
Non-Invasive Cancer Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Non-Invasive Cancer Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
CTCs
CTNAS
Exosomes

Market segment by Application, split into
Blood
Urine
Saliva

Based on regional and country-level analysis, the Non-Invasive Cancer Diagnostics market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Non-Invasive Cancer Diagnostics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Gen-Probe Inc
Digene Corporation
Quest Diagnostics Inc
Cancer, Genetics Inc
BIOVIEW Inc
AVIVA Biosciences Corporation
Laboratory Corporation of America Holdings (LabCorp)
A&G Pharmaceutical
Affymetrix Inc
Precision Therapeutics

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-Invasive Cancer Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 CTCs
1.2.3 CTNAS
1.2.4 Exosomes
1.3 Market by Application
1.3.1 Global Non-Invasive Cancer Diagnostics Market Share by Application: 2020 VS 2026
1.3.2 Blood
1.3.3 Urine
1.3.4 Saliva
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Non-Invasive Cancer Diagnostics Market Perspective (2015-2026)
2.2 Global Non-Invasive Cancer Diagnostics Growth Trends by Regions
2.2.1 Non-Invasive Cancer Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Non-Invasive Cancer Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Non-Invasive Cancer Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Non-Invasive Cancer Diagnostics Players by Market Size
3.1.1 Global Top Non-Invasive Cancer Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Non-Invasive Cancer Diagnostics Revenue Market Share by Players (2015-2020)
3.2 Global Non-Invasive Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Non-Invasive Cancer Diagnostics Revenue
3.4 Global Non-Invasive Cancer Diagnostics Market Concentration Ratio
3.4.1 Global Non-Invasive Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-Invasive Cancer Diagnostics Revenue in 2019
3.5 Key Players Non-Invasive Cancer Diagnostics Area Served
3.6 Key Players Non-Invasive Cancer Diagnostics Product Solution and Service
3.7 Date of Enter into Non-Invasive Cancer Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Non-Invasive Cancer Diagnostics Breakdown Data by Type (2015-2026)
4.1 Global Non-Invasive Cancer Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Non-Invasive Cancer Diagnostics Forecasted Market Size by Type (2021-2026)

5 Non-Invasive Cancer Diagnostics Breakdown Data by Application (2015-2026)
5.1 Global Non-Invasive Cancer Diagnostics Historic Market Size by Application (2015-2020)
5.2 Global Non-Invasive Cancer Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Non-Invasive Cancer Diagnostics Market Size (2015-2026)
6.2 North America Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020)
6.3 North America Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020)
6.4 North America Non-Invasive Cancer Diagnostics Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada

7 Europe
7.1 Europe Non-Invasive Cancer Diagnostics Market Size (2015-2026)
7.2 Europe Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020)
7.3 Europe Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020)
7.4 Europe Non-Invasive Cancer Diagnostics Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe

8 China
8.1 China Non-Invasive Cancer Diagnostics Market Size (2015-2026)
8.2 China Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020)
8.3 China Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020)
8.4 China Non-Invasive Cancer Diagnostics Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific

9 Japan
9.1 Japan Non-Invasive Cancer Diagnostics Market Size (2015-2026)
9.2 Japan Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020)
9.3 Japan Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020)
9.4 Japan Non-Invasive Cancer Diagnostics Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil

10 Southeast Asia
10.1 Southeast Asia Non-Invasive Cancer Diagnostics Market Size (2015-2026)
10.2 Southeast Asia Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020)
10.3 Southeast Asia Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020)
10.4 Southeast Asia Non-Invasive Cancer Diagnostics Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa

11 Key Players Profiles
11.1 Gen-Probe Inc
11.1.1 Gen-Probe Inc Company Details
11.1.2 Gen-Probe Inc Business Overview
11.1.3 Gen-Probe Inc Non-Invasive Cancer Diagnostics Introduction
11.1.4 Gen-Probe Inc Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020))
11.1.5 Gen-Probe Inc Recent Development
11.2 Digene Corporation
11.2.1 Digene Corporation Company Details
11.2.2 Digene Corporation Business Overview
11.2.3 Digene Corporation Non-Invasive Cancer Diagnostics Introduction
11.2.4 Digene Corporation Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020)
11.2.5 Digene Corporation Recent Development
11.3 Quest Diagnostics Inc
11.3.1 Quest Diagnostics Inc Company Details
11.3.2 Quest Diagnostics Inc Business Overview
11.3.3 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Introduction
11.3.4 Quest Diagnostics Inc Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020)
11.3.5 Quest Diagnostics Inc Recent Development
11.4 Cancer, Genetics Inc
11.4.1 Cancer, Genetics Inc Company Details
11.4.2 Cancer, Genetics Inc Business Overview
11.4.3 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Introduction
11.4.4 Cancer, Genetics Inc Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020)
11.4.5 Cancer, Genetics Inc Recent Development
11.5 BIOVIEW Inc
11.5.1 BIOVIEW Inc Company Details
11.5.2 BIOVIEW Inc Business Overview
11.5.3 BIOVIEW Inc Non-Invasive Cancer Diagnostics Introduction
11.5.4 BIOVIEW Inc Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020)
11.5.5 BIOVIEW Inc Recent Development
11.6 AVIVA Biosciences Corporation
11.6.1 AVIVA Biosciences Corporation Company Details
11.6.2 AVIVA Biosciences Corporation Business Overview
11.6.3 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Introduction
11.6.4 AVIVA Biosciences Corporation Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020)
11.6.5 AVIVA Biosciences Corporation Recent Development
11.7 Laboratory Corporation of America Holdings (LabCorp)
11.7.1 Laboratory Corporation of America Holdings (LabCorp) Company Details
11.7.2 Laboratory Corporation of America Holdings (LabCorp) Business Overview
11.7.3 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Introduction
11.7.4 Laboratory Corporation of America Holdings (LabCorp) Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020)
11.7.5 Laboratory Corporation of America Holdings (LabCorp) Recent Development
11.8 A&G Pharmaceutical
11.8.1 A&G Pharmaceutical Company Details
11.8.2 A&G Pharmaceutical Business Overview
11.8.3 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Introduction
11.8.4 A&G Pharmaceutical Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020)
11.8.5 A&G Pharmaceutical Recent Development
11.9 Affymetrix Inc
11.9.1 Affymetrix Inc Company Details
11.9.2 Affymetrix Inc Business Overview
11.9.3 Affymetrix Inc Non-Invasive Cancer Diagnostics Introduction
11.9.4 Affymetrix Inc Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020)
11.9.5 Affymetrix Inc Recent Development
11.10 Precision Therapeutics
11.10.1 Precision Therapeutics Company Details
11.10.2 Precision Therapeutics Business Overview
11.10.3 Precision Therapeutics Non-Invasive Cancer Diagnostics Introduction
11.10.4 Precision Therapeutics Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020)
11.10.5 Precision Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Tables and Figures

List of Tables
Table 1. Global Non-Invasive Cancer Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of CTCs
Table 4. Key Players of CTNAS
Table 5. Key Players of Exosomes
Table 6. Global Non-Invasive Cancer Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 7. Global Non-Invasive Cancer Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 8. Global Non-Invasive Cancer Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 9. Global Non-Invasive Cancer Diagnostics Market Share by Regions (2015-2020)
Table 10. Global Non-Invasive Cancer Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 11. Global Non-Invasive Cancer Diagnostics Market Share by Regions (2021-2026)
Table 12. Non-Invasive Cancer Diagnostics Market Market Trends
Table 13. Non-Invasive Cancer Diagnostics Market Drivers
Table 14. Non-Invasive Cancer Diagnostics Market Challenges
Table 15. Non-Invasive Cancer Diagnostics Market Restraints
Table 16. Global Non-Invasive Cancer Diagnostics Revenue by Players (2015-2020) (US$ Million)
Table 17. Global Non-Invasive Cancer Diagnostics Market Share by Players (2015-2020)
Table 18. Global Top Non-Invasive Cancer Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Invasive Cancer Diagnostics as of 2019)
Table 19. Global Non-Invasive Cancer Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Non-Invasive Cancer Diagnostics Product Solution and Service
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 24. Global Non-Invasive Cancer Diagnostics Market Size Share by Type (2015-2020)
Table 25. Global Non-Invasive Cancer Diagnostics Revenue Market Share by Type (2021-2026)
Table 26. Global Non-Invasive Cancer Diagnostics Market Size Share by Application (2015-2020)
Table 27. Global Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 28. Global Non-Invasive Cancer Diagnostics Market Size Share by Application (2021-2026)
Table 29. North America Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 30. North America Non-Invasive Cancer Diagnostics Market Share by Type (2015-2020)
Table 31. North America Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 32. North America Non-Invasive Cancer Diagnostics Market Share by Application (2015-2020)
Table 33. North America Non-Invasive Cancer Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 34. North America Non-Invasive Cancer Diagnostics Market Share by Country (2015-2020)
Table 35. Europe Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 36. Europe Non-Invasive Cancer Diagnostics Market Share by Type (2015-2020)
Table 37. Europe Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 38. Europe Non-Invasive Cancer Diagnostics Market Share by Application (2015-2020)
Table 39. Europe Non-Invasive Cancer Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 40. Europe Non-Invasive Cancer Diagnostics Market Share by Country (2015-2020)
Table 41. China Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 42. China Non-Invasive Cancer Diagnostics Market Share by Type (2015-2020)
Table 43. China Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 44. China Non-Invasive Cancer Diagnostics Market Share by Application (2015-2020)
Table 45. China Non-Invasive Cancer Diagnostics Market Size by Region (US$ Million) (2015-2020)
Table 46. China Non-Invasive Cancer Diagnostics Market Share by Region (2015-2020)
Table 47. Japan Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 48. Japan Non-Invasive Cancer Diagnostics Market Share by Type (2015-2020)
Table 49. Japan Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 50. Japan Non-Invasive Cancer Diagnostics Market Share by Application (2015-2020)
Table 51. Japan Non-Invasive Cancer Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 52. Japan Non-Invasive Cancer Diagnostics Market Share by Country (2015-2020)
Table 53. Southeast Asia Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 54. Southeast Asia Non-Invasive Cancer Diagnostics Market Share by Type (2015-2020)
Table 55. Southeast Asia Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 56. Southeast Asia Non-Invasive Cancer Diagnostics Market Share by Application (2015-2020)
Table 57. Southeast Asia Non-Invasive Cancer Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 58. Southeast Asia Non-Invasive Cancer Diagnostics Market Share by Country (2015-2020)
Table 59. Gen-Probe Inc Company Details
Table 60. Gen-Probe Inc Business Overview
Table 61. Gen-Probe Inc Product
Table 62. Gen-Probe Inc Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020) (US$ Million)
Table 63. Gen-Probe Inc Recent Development
Table 64. Digene Corporation Company Details
Table 65. Digene Corporation Business Overview
Table 66. Digene Corporation Product
Table 67. Digene Corporation Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020) (US$ Million)
Table 68. Digene Corporation Recent Development
Table 69. Quest Diagnostics Inc Company Details
Table 70. Quest Diagnostics Inc Business Overview
Table 71. Quest Diagnostics Inc Product
Table 72. Quest Diagnostics Inc Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020) (US$ Million)
Table 73. Quest Diagnostics Inc Recent Development
Table 74. Cancer, Genetics Inc Company Details
Table 75. Cancer, Genetics Inc Business Overview
Table 76. Cancer, Genetics Inc Product
Table 77. Cancer, Genetics Inc Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020) (US$ Million)
Table 78. Cancer, Genetics Inc Recent Development
Table 79. BIOVIEW Inc Company Details
Table 80. BIOVIEW Inc Business Overview
Table 81. BIOVIEW Inc Product
Table 82. BIOVIEW Inc Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020) (US$ Million)
Table 83. BIOVIEW Inc Recent Development
Table 84. AVIVA Biosciences Corporation Company Details
Table 85. AVIVA Biosciences Corporation Business Overview
Table 86. AVIVA Biosciences Corporation Product
Table 87. AVIVA Biosciences Corporation Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020) (US$ Million)
Table 88. AVIVA Biosciences Corporation Recent Development
Table 89. Laboratory Corporation of America Holdings (LabCorp) Company Details
Table 90. Laboratory Corporation of America Holdings (LabCorp) Business Overview
Table 91. Laboratory Corporation of America Holdings (LabCorp) Product
Table 92. Laboratory Corporation of America Holdings (LabCorp) Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020) (US$ Million)
Table 93. Laboratory Corporation of America Holdings (LabCorp) Recent Development
Table 94. A&G Pharmaceutical Business Overview
Table 95. A&G Pharmaceutical Product
Table 96. A&G Pharmaceutical Company Details
Table 97. A&G Pharmaceutical Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020) (US$ Million)
Table 98. A&G Pharmaceutical Recent Development
Table 99. Affymetrix Inc Company Details
Table 100. Affymetrix Inc Business Overview
Table 101. Affymetrix Inc Product
Table 102. Affymetrix Inc Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020) (US$ Million)
Table 103. Affymetrix Inc Recent Development
Table 104. Precision Therapeutics Company Details
Table 105. Precision Therapeutics Business Overview
Table 106. Precision Therapeutics Product
Table 107. Precision Therapeutics Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020) (US$ Million)
Table 108. Precision Therapeutics Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non-Invasive Cancer Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. CTCs Features
Figure 3. CTNAS Features
Figure 4. Exosomes Features
Figure 5. Global Non-Invasive Cancer Diagnostics Market Share by Application: 2020 VS 2026
Figure 6. Blood Case Studies
Figure 7. Urine Case Studies
Figure 8. Saliva Case Studies
Figure 9. Non-Invasive Cancer Diagnostics Report Years Considered
Figure 10. Global Non-Invasive Cancer Diagnostics Market Size (US$ Million), YoY Growth 2015-2026
Figure 11. Global Non-Invasive Cancer Diagnostics Market Share by Regions: 2020 VS 2026
Figure 12. Global Non-Invasive Cancer Diagnostics Market Share by Regions (2021-2026)
Figure 13. Global Non-Invasive Cancer Diagnostics Market Share by Players in 2019
Figure 14. Global Top Non-Invasive Cancer Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Invasive Cancer Diagnostics as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Non-Invasive Cancer Diagnostics Revenue in 2019
Figure 16. North America Non-Invasive Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. United States Non-Invasive Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Canada Non-Invasive Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Europe Non-Invasive Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Germany Non-Invasive Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. France Non-Invasive Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. U.K. Non-Invasive Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Italy Non-Invasive Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Russia Non-Invasive Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Nordic Non-Invasive Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Rest of Europe Non-Invasive Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Asia-Pacific Non-Invasive Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. China Non-Invasive Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Japan Non-Invasive Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. South Korea Non-Invasive Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Southeast Asia Non-Invasive Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. India Non-Invasive Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Australia Non-Invasive Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Rest of Asia-Pacific Non-Invasive Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Latin America Non-Invasive Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Mexico Non-Invasive Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Brazil Non-Invasive Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Middle East & Africa Non-Invasive Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Turkey Non-Invasive Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Saudi Arabia Non-Invasive Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. UAE Non-Invasive Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Rest of Middle East & Africa Non-Invasive Cancer Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Gen-Probe Inc Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2015-2020)
Figure 44. Digene Corporation Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2015-2020)
Figure 45. Quest Diagnostics Inc Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2015-2020)
Figure 46. Cancer, Genetics Inc Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2015-2020)
Figure 47. BIOVIEW Inc Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2015-2020)
Figure 48. AVIVA Biosciences Corporation Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2015-2020)
Figure 49. Laboratory Corporation of America Holdings (LabCorp) Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2015-2020)
Figure 50. A&G Pharmaceutical Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2015-2020)
Figure 51. Affymetrix Inc Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2015-2020)
Figure 52. Precision Therapeutics Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2015-2020)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed

Companies Covered

Gen-Probe Inc
Digene Corporation
Quest Diagnostics Inc
Cancer, Genetics Inc
BIOVIEW Inc
AVIVA Biosciences Corporation
Laboratory Corporation of America Holdings (LabCorp)
A&G Pharmaceutical
Affymetrix Inc
Precision Therapeutics

Report License Types

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Report Enquiry

Do you need more information about this report before making a purchase decision or wish to customize this report to suite your requirements?

If yes, then please use the form given below and we will get in touch with you immediately.

Kindly use your official email address and contact number to ensure speedy response.

Name *

Email *

Company

Contact Number *

Report Title *

Your Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Drag or click the correct shape to the grey "drop area".